Kevin Mathews - 25 Jul 2022 Form 4 Insider Report for Acutus Medical, Inc. (AFIB)

Role: SVP, Global Sales
Signature: /s/ Tom Sohn as attorney-in-fact for Kevin Mathews
Issuer symbol: AFIB
Transactions as of: 25 Jul 2022
Net transactions value: $0
Form type: 4
Filing time: 01 Aug 2022, 18:04:40 UTC
Previous filing: 01 Aug 2022
Next filing: 09 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	AFIB	Common Stock						27,827	25 Jul 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AFIB	Employee Stock Options (Right to Buy)	Disposed to Issuer		-21,583	-38%		35,467	25 Jul 2022	Common Stock	21,583	$18.00	Direct	F1
transaction	AFIB	Employee Stock Options (Right to Buy)	Award		+21,583	+61%		57,050	25 Jul 2022	Common Stock	21,583	$1.34	Direct	F1
transaction	AFIB	Employee Stock Options (Right to Buy)	Disposed to Issuer		-15,467	-27%		41,583	25 Jul 2022	Common Stock	15,467	$13.66	Direct	F2
transaction	AFIB	Employee Stock Options (Right to Buy)	Award		+15,647	+38%		57,050	25 Jul 2022	Common Stock	15,467	$1.34	Direct	F2
transaction	AFIB	Employee Stock Options (Right to Buy)	Disposed to Issuer		-20,000	-35%		37,050	25 Jul 2022	Common Stock	20,000	$2.41	Direct	F3
transaction	AFIB	Employee Stock Options (Right to Buy)	Award		+20,000	+54%		57,050	25 Jul 2022	Common Stock	20,000	$1.34	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The two reported transactions involved an amendment of an outstanding option reducing the exercise price of the option. The option was originally granted on August 5, 2020, with 1/4 vesting on the first anniversary of the vesting commencement date, and the remainder vesting in 36 equal monthly installments.
F2	The two reported transactions involved an amendment of an outstanding option reducing the exercise price of the option. The option was originally granted on April 1, 2021, with 1/4 vesting on the first anniversary of the vesting commencement date, and the remainder vesting in 36 equal monthly installments.
F3	The two reported transactions involved an amendment of an outstanding option reducing the exercise price of the option. The option was originally granted on February 1, 2022, with 1/2 vesting on the first anniversary of the vesting commencement date, and the remainder vesting in 12 equal monthly installments.